DiaSorin Receives FDA Clearance for EBV Assays
DiaSorin has received Food and Drug Administration (FDA) clearance for its LIAISON® Epstein-Barr Virus (EBV) assays, including VCA IgM, VCA IgG, and EBNA IgG. The company introduced its first line of EBV ELISA tests in 1989, and currently serves r
Read More